THC plays a large role in why cannabis is still classified as a Schedule 1 Drug. The DEA doesn’t consider cannabis to be a medicinal plant due to the psychoactive effects of this cannabinoid. With that being said, the FDA is taking a closer look at hemp and other cannabinoids—including CBD—and their therapeutic properties. This has not only resulted in the declassification of CBD to a Schedule 5 Substance but the FDA has also approved several CBD medications.